Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.

Hologic stopped manufacturing the device after reports of serious adverse events in patients who had the markers implanted in breast tissue.

A report found China limits EU-based device manufacturers’ access to its market through policies that favor local suppliers in an “unfair and discriminatory way.” ...

FetalEase is a privately held Israeli start-up company dedicated to commercializing the Yaari Extractor, a simple mechanical device that resolves shoulder dystocia, an obstetric emergency in which the ...

Massimiliano Colella joined the robot maker as chief commercial officer in 2023 and stepped into the top job when former CEO ...

New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, ...

Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed ...

After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued ...

Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and ...

Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the second half of the year.

Norm has received breakthrough device designation from the Food and Drug Administration, giving Fire1 additional access to ...

Stryker made several small deals last year but lacked a larger acquisition like its nearly $5 billion proposal for Inari ...